An immuno-therapy platform in development: AbstimX™

Scientists at Network Immunology Inc. have discovered how to prevent development of inflammatory breast cancer, prevent development of inflammatory colitis, and to treat allergy, all with the same immuno-therapeutic,  AbstimX™.

We have seen that a single type of two-component treatment is effective in preventing breast cancer and preventing inflammatory bowel disease in mouse models.  Further, the same two-component treatment is an effective treatment of egg white allergy in a mouse model.

Network Immunology welcomes collaborators and accredited investors to be a part of this venture.

For investment information, please contact George Hoffmann at






Corporate Updates

Captcha Image